• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 2, 2016

View Archived Issues

New biomarkers in rheumatoid disease presented at ACR meeting

Read More

Arsanis' ASN-100 receives FDA fast track designation

Read More

ABC-1183, a novel GSK3/CDK9 inhibitor

Read More

EC grants orphan designation to Agilis Biotherapeutics' AGIL-AADC

Read More

AmorePacific initiates phase III trial of PAC-14028 in atopic dermatitis

Read More

Vertex initiates phase II study of VX-152 combination therapy for cystic fibrosis

Read More

A first-in-class small-molecule inhibitor of PD-L1 and TIM-3

Read More

Daiichi Sankyo's DS-8201 given FDA fast track designation

Read More

First phase Ia/b data for anti-RSPO3 antibody OMP-131R10 in advanced solid tumors

Read More

City of Hope and TGen form alliance to advance precision medicine

Read More

Axial Biotherapeutics launches with series A financing

Read More

Portage Biotech forms new ophthalmic-focused company

Read More

Kalyra Pharmaceuticals patents EGFR inhibitors

Read More

Wistar Institute discloses EBNA-1 inhibitors

Read More

GlaxoSmithKline describes RIP-1 kinase 1 inhibitors

Read More

Medshine Discovery develops PDE2A inhibitors and TNF-alpha production inhibitors

Read More

Kainos Medicine presents Brd4 inhibitors

Read More

Aequus BioPharma synthesizes melanocortin fusion peptide for treating gout

Read More

IONIS-ANGPTL3-LRx shows potential to reduce plasma ANGPTL3 and lipids

Read More

Ferring Pharmaceuticals and Ache Laboratorios Farmaceuticos form nanotechnology collaboration

Read More

Biophytis' Sarconeos safe in SARA-PK clinical study

Read More

Aradigm reports topline results from ORBIT-3 and -4 studies of Pulmaquin

Read More

Inovio Pharmaceuticals awarded grant for MAb against Zika virus

Read More

GALACTIC-HF phase III trial of omecamtiv mecarbil begins

Read More

HDAC6 inhibitor ACY-241 given U.S. orphan status for multiple myeloma

Read More

Dosing begins in phase I/II study of Agenus' INCAGN-1949

Read More

Shire's Cinryze granted U.S. orphan status for acute antibody-mediated renal transplant rejection

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe